Fig. 13From: Spider venom components decrease glioblastoma cell migration and invasion through RhoA-ROCK and Na+/K+-ATPase β2: potential molecular entities to treat invasive brain cancerROCK and Na+/K+-ATPase expression assessed by Western blotting. The expression of ROCK was significantly increased after 5 h of both treatments (SF1 and SF11) (a). The expression of Na+/K+-ATPase (AMOG) was significantly increased after 5 h of treatment with SF11 (b). *P < 0.05 and **P < 0.01, compared to the untreated control. Results of three independent experimentsBack to article page